Kits and methods to distinguish false labor and true labor

US12287340B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12287340-B2
Application numberUS-202418414339-A
CountryUS
Kind codeB2
Filing dateJan 16, 2024
Priority dateNov 5, 2015
Publication dateApr 29, 2025
Grant dateApr 29, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Kits and methods to distinguish between false and true labor are provided. The kits and methods can utilize differences in abundance and/or differences in the rate of change in abundance of B7-H2, SORC2, TF, C1-Esterase Inhibitor, Ran, IMDH1 and/or PGAM1, as markers of true labor.

First claim

Opening claim text (preview).

What is claimed is: 1. A kit comprising: an array that measures tissue factor (TF) in combination with Ras-related Nuclear protein (Ran), Inosine-5′-monophosphate dehydrogenase (IMDH1), and Phosphoglycerate mutase 1 (PGAM1), from a sample obtained from a pregnant female. 2. The kit of claim 1 comprising instructions that direct calculation of changes in abundance (CA) of TF, Ran, IMDH1, and PGAM1 as compared to a reference level calculated from samples derived from a reference population, at a time when members of said reference population were not in true labor. 3. The kit of claim 2 comprising instructions that direct calculation of a true labor score using change of abundance of true labor markers, wherein CA TF , CA Ran , CA IMDH1 , and CA PGAM1 are used in a Linear Discriminant Analysis Model. 4. The kit of claim 3 comprising instructions that direct analysis of the true labor score; wherein the true labor score comprises two threshold values, X and Y, wherein a true labor score≤X denotes that the pregnant female is in false labor, and wherein a true labor score>Y denotes that the pregnant female is in true labor. 5. The kit of claim 1 , comprising instructions that direct sample collection be obtained from a pregnant female between 33 and 40 weeks of the female's pregnancy. 6. The kit of claim 1 , comprising instructions to collect a plasma or serum sample. 7. The kit of claim 1 , comprising instructions to collect the sample when the pregnant female is experiencing symptoms associated with false labor and true labor, wherein the symptoms optionally are contractions. 8. The kit of claim 1 , wherein the array comprises one or more well(s) coated with: anti-TF antibodies; and/or anti-Ran antibodies; and/or anti-IMDH1 antibodies; and/or anti-PGAM1 antibodies.

Assignees

Inventors

Classifications

  • for evaluating statistical data {, e.g. average values, frequency distributions, probability functions, regression analysis (forecasting specially adapted for a specific administrative, business or logistic context G06Q10/04)} · CPC title

  • Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour · CPC title

  • Calcium binding proteins, e.g. calmodulin · CPC title

  • with an insoluble carrier for immobilising immunochemicals · CPC title

  • Phosphotransferases (phosphomutases) (5.4.2) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12287340B2 cover?
Kits and methods to distinguish between false and true labor are provided. The kits and methods can utilize differences in abundance and/or differences in the rate of change in abundance of B7-H2, SORC2, TF, C1-Esterase Inhibitor, Ran, IMDH1 and/or PGAM1, as markers of true labor.
Who is the assignee on this patent?
Univ Wayne State, The Us Secretary Department Of Health & Human Services
What technology area does this patent fall under?
Primary CPC classification G01N33/689. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).